Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2016-05-31 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly references Article 26a of the WpHG (German Securities Trading Act). It announces a specific number of total voting rights (132,798,546) resulting from a 'Conditional capital increase' or 'Other capital measure'. This type of announcement, dealing with the total number of shares/voting rights, is a specific regulatory disclosure. It is not a full annual report (10-K), an earnings release (ER), or a general management/board change (MANG). While it relates to capital structure, the core purpose is the mandatory disclosure of the total voting rights count, which fits best under the general regulatory announcement category, RNS, as it is a specific regulatory filing that doesn't map perfectly to CAP (Capital/Financing Update) which usually covers fundraising activities or debt issuance, or SHA (Share Issue/Capital Change) which is broader. Given the context of mandatory disclosure under German law regarding voting rights, RNS (Regulatory Filings) is the most appropriate general classification for this specific regulatory notice.
2016-05-31 English
Evotec extends integrated drug discovery alliance with Genentech
Regulatory Filings Classification · 100% confidence The document is a press release announcing the extension of a drug discovery alliance between Evotec AG and Genentech. It uses standard press release formatting, including a date, headline, and boilerplate 'ABOUT' and 'FORWARD LOOKING STATEMENTS' sections. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a general corporate announcement regarding business operations and partnerships. Since it does not fit into specific categories like M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), the most appropriate fallback category is Regulatory Filings (RNS), which covers general corporate news disseminated via services like DGAP.
2016-05-24 English
Evotec AG reports results of first quarter 2016
Earnings Release Classification · 100% confidence The document explicitly states, "Evotec AG reports results of first quarter 2016" and provides detailed financial performance metrics (revenues, EBITDA, R&D expenses) for Q1 2016, comparing them to the previous year. It also includes management updates and confirms the 2016 guidance. This content structure—a comprehensive summary of financial results for a specific interim period (Q1)—is characteristic of an Interim/Quarterly Report. Although it mentions a conference call, the primary content is the financial results themselves, not just the announcement of the report's release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2016
2016-05-10 English
Präsentation Q1
Investor Presentation Classification · 95% confidence The document is a slide deck presentation titled 'EVT Execute & EVT Innovate' for Q1 2016. It contains financial highlights, business updates, and strategic outlooks typical of an investor presentation. It is not a full quarterly report (IR) as it lacks the formal financial statements and notes required for such filings, nor is it a transcript (CT). It is clearly designed for investor communication, making it an Investor Presentation. Q1 2016
2016-05-10 English
Q1 statement / Q1 financial report 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Statement Q1 2016' and contains comprehensive financial data, including consolidated interim statements of financial position and income statements for the three-month period ending March 31, 2016. It provides detailed analysis of business segments, R&D expenses, and cash flow, which fits the definition of an Interim/Quarterly Report (IR). It is not merely an announcement or a certification, as it contains the actual financial statements. Q1 2016
2016-05-10 German
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled 'DGAP Voting Rights Announcement' and contains sections detailing 'Notification of Major Holdings' regarding the acquisition/disposal of shares with voting rights, referencing German securities law (WpHG Sections 21, 22, 25). This directly corresponds to the definition of reporting changes in significant share ownership thresholds. The most specific category for this type of filing is 'Major Shareholding Notification' (MRQ). Although it is a regulatory announcement, MRQ is more specific than the general 'RNS' fallback.
2016-05-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.